A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab

Overview of attention for article published in Breast Cancer Research and Treatment, March 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

wikipedia: 6 Wikipedia pages

Citations

dimensions_citation: 179 Dimensions

Readers on

mendeley: 108 Mendeley

Summary Wikipedia Dimensions citations

So far, Altmetric has seen 6 citations on 6 Wikipedia pages.

آفاتینیب

Cited by user Tisfoon on 21 Dec 2021

Afatinib

Cited by user Fabricas on 24 Sep 2019

Afatinib

Cited by user Lanhsmp on 28 Aug 2018

Afatinib

Cited by user Annelise.vonbergen on 29 Dec 2015

アファチニブ

Cited by user Utataneko on 26 Jan 2015

Afatinib

Cited by user Anypodetos on 20 Jul 2012

Afatinib (INN; trade name Gilotrif in the US and Giotrif in Europe, previously Tomtovok and Tovok) is a drug approved in United States, Europe, Taiwan, Mexico, Chile and…